Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Ningetinib |
Trade Name | |
Synonyms | CT053PTSA|CT-053-PTSA |
Drug Descriptions |
Ningetinib (CT053PTSA) inhibits MET, VEGFR2, AXL, and FLT3, which potentially reduces tumor cell growth (PMID: 36341335, PMID: 38978049). |
DrugClasses | AXL Inhibitor 30 FLT3 Inhibitor 69 MET Inhibitor 59 VEGFR2 Inhibitor 37 |
CAS Registry Number | 1394820-69-9 |
NCIT ID | C148529 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Gefitinib + Ningetinib | Gefitinib Ningetinib | 0 | 0 |
Ningetinib | Ningetinib | 8 | 0 |